Open AccessPRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Author(s) -
Hiroaki Matsubara,
Takeshi Fukuda,
Yuichiro Awazu,
Shigenori Nanno,
Masahiro Shimomura,
Yuta Inoue,
M. Yamauchi,
Tomoyo Yasui,
Toshiyuki Sumi
Publication year - 2020
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2020.12423
Subject(s) - carboplatin , cisplatin , cancer research , chemotherapy , ovarian cancer , molecular medicine , oncogene , biology , serous fluid , debulking , oncology , apoptosis , cancer , cell cycle , medicine , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom